首页 > 最新文献

In vivo最新文献

英文 中文
Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor Monotherapy. PD-1/PD-L1抑制剂单药治疗中多系统免疫相关不良事件与无进展生存率之间的关系
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13770
Atsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, Ayako Furugen, Katsuya Narumi, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, Mitsuru Sugawara, Masaki Kobayashi

Background/aim: Immune-related adverse events (irAEs) occur in various organs, and sometimes multiply following treatment with immune checkpoint inhibitors (ICIs). This study aimed to determine the association between the number of irAEs and clinical outcomes.

Patients and methods: This was a retrospective study that included patients with lung cancer, melanoma, and head and neck cancer who were treated with anti-programmed cell death (ligand) 1 (PD-1/PD-L1) monotherapy. We evaluated the association between the number of irAEs and progression-free survival (PFS) in the simple Cox regression analysis. To eliminate the immortal-time bias, an additional landmark analysis was performed.

Results: In total, 92, 69, and 37 patients were allocated to the no, single, and multisystem irAEs groups, respectively. The multisystem irAEs were associated with better PFS compared to the no irAE group. In contrast, at the 12-week landmark, multisystem irAEs were associated with poor PFS compared to the no irAEs group. Furthermore, the rate of treatment suspension owing to irAEs in the multisystem irAEs group (62.5%) was higher than that in the single irAE group (17.3%) at the 12-week landmark.

Conclusion: The incidence of multisystem irAEs was associated with improved clinical outcomes in patients with lung cancer, melanoma, and head and neck cancer treated with PD-1/PD-L1 inhibitor monotherapy. However, these results may be influenced by a potential immortal-time bias. When accounting for this bias, the early development of multisystem irAEs within 12 weeks was linked to treatment suspension and poorer clinical outcomes.

背景/目的:免疫检查点抑制剂(ICIs)治疗后,免疫相关不良事件(irAEs)会发生在不同器官,有时还会成倍增加。本研究旨在确定irAEs数量与临床结果之间的关联:这是一项回顾性研究,纳入了接受抗程序性细胞死亡(配体)1(PD-1/PD-L1)单药治疗的肺癌、黑色素瘤和头颈癌患者。我们通过简单的考克斯回归分析评估了irAEs数量与无进展生存期(PFS)之间的关系。为了消除不死时间偏差,我们还进行了额外的地标分析:共有92、69和37名患者分别被分配到无irAEs组、单系统irAEs组和多系统irAEs组。与无irAE组相比,多系统irAE与更好的PFS相关。相反,与无irAEs组相比,在12周时点,多系统irAEs与较差的PFS相关。此外,在12周时点,多系统irAEs组因irAEs而中止治疗的比例(62.5%)高于单系统irAEs组(17.3%):结论:在接受PD-1/PD-L1抑制剂单药治疗的肺癌、黑色素瘤和头颈癌患者中,多系统irAEs的发生率与临床预后的改善相关。然而,这些结果可能会受到潜在不死时间偏差的影响。如果考虑到这种偏倚,12周内早期出现多系统irAEs与治疗中止和较差的临床预后有关。
{"title":"Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor Monotherapy.","authors":"Atsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, Ayako Furugen, Katsuya Narumi, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, Mitsuru Sugawara, Masaki Kobayashi","doi":"10.21873/invivo.13770","DOIUrl":"10.21873/invivo.13770","url":null,"abstract":"<p><strong>Background/aim: </strong>Immune-related adverse events (irAEs) occur in various organs, and sometimes multiply following treatment with immune checkpoint inhibitors (ICIs). This study aimed to determine the association between the number of irAEs and clinical outcomes.</p><p><strong>Patients and methods: </strong>This was a retrospective study that included patients with lung cancer, melanoma, and head and neck cancer who were treated with anti-programmed cell death (ligand) 1 (PD-1/PD-L1) monotherapy. We evaluated the association between the number of irAEs and progression-free survival (PFS) in the simple Cox regression analysis. To eliminate the immortal-time bias, an additional landmark analysis was performed.</p><p><strong>Results: </strong>In total, 92, 69, and 37 patients were allocated to the no, single, and multisystem irAEs groups, respectively. The multisystem irAEs were associated with better PFS compared to the no irAE group. In contrast, at the 12-week landmark, multisystem irAEs were associated with poor PFS compared to the no irAEs group. Furthermore, the rate of treatment suspension owing to irAEs in the multisystem irAEs group (62.5%) was higher than that in the single irAE group (17.3%) at the 12-week landmark.</p><p><strong>Conclusion: </strong>The incidence of multisystem irAEs was associated with improved clinical outcomes in patients with lung cancer, melanoma, and head and neck cancer treated with PD-1/PD-L1 inhibitor monotherapy. However, these results may be influenced by a potential immortal-time bias. When accounting for this bias, the early development of multisystem irAEs within 12 weeks was linked to treatment suspension and poorer clinical outcomes.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2886-2896"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioinformatics Analysis and Experimental Validation of Epigallocatechin-3-gallate Against Iopromide-induced Injury in HEK-293 Cells via Anti-oxidative and Anti-inflammation Pathways. 表没食子儿茶素-3-没食子酸酯通过抗氧化和抗炎途径对抗碘溴铵诱导的 HEK-293 细胞损伤的生物信息学分析和实验验证
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13738
Yuh-Feng Tsai, Chia-Wen Tsai, Jai-Sing Yang, Yu-Ning Juan, Hou-Yu Shih, DA-Tian Bau, Wen-Shin Chang

Background/aim: The administration of contrast agents can adversely affect kidney function. Nevertheless, the nephrotoxicity of iopromide in human renal cells, potential therapeutic agents, and the underlying molecular mechanisms have not been thoroughly investigated.

Materials and methods: The proliferation of HEK-293 kidney cells was assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazoliumbromide (MTT) assay. Apoptotic cell death was examined using the TUNEL assay and caspase-3 activity measurements. The impacts and potential pathways of epigallocatechin-3-gallate (EGCG) on iopromide-induced renal damage were analyzed through whole transcriptome sequencing. The redox state was assessed by measuring reactive oxygen species (ROS) production and 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity.

Results: Iopromide-induced inhibition of cell proliferation and apoptosis in HEK-293 cells was counteracted by EGCG co-treatment. Pathway analysis revealed that molecules related to antioxidant and anti-inflammatory responses, such as ERK1/2, STAT1, and NF-[Formula: see text]B, were pivotal in the action of EGCG.

Conclusion: Iopromide-induced ROS production, decreased DPPH scavenging ability, DNA strand breaks, elevated caspase-3 activity, and reduced cell proliferation were all reversed by EGCG co-treatment in HEK-293 cells. The mechanisms likely involve the attenuation of oxidative stress, inflammatory responses, and apoptosis, with regulation through the ERK1/2, STAT1, and NF-[Formula: see text]B pathways. Further research is necessary to confirm the protective effects of EGCG on renal function, particularly against damage induced by contrast agents like iopromide.

背景/目的:使用造影剂会对肾功能产生不利影响。然而,有关碘普罗米特对人肾脏细胞的肾毒性、潜在的治疗药物以及潜在的分子机制尚未得到深入研究:采用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑(MTT)试验评估 HEK-293 肾细胞的增殖情况。细胞凋亡采用 TUNEL 法和 caspase-3 活性测定法进行检测。通过全转录组测序分析了表没食子儿茶素-3-棓酸盐(EGCG)对碘普罗胺诱导的肾损伤的影响和潜在途径。通过测量活性氧(ROS)的产生和 2,2-二苯基-1-苦基肼(DPPH)自由基清除活性来评估氧化还原状态:结果:与 EGCG 共同处理可抑制 Iopromide 诱导的 HEK-293 细胞增殖和凋亡。通路分析表明,与抗氧化和抗炎反应有关的分子,如 ERK1/2、STAT1 和 NF-[式中:见正文]B,在 EGCG 的作用中起着关键作用:结论:在HEK-293细胞中,EGCG联合处理可逆转碘溴铵诱导的ROS产生、DPPH清除能力下降、DNA链断裂、caspase-3活性升高和细胞增殖减少。其机制可能涉及氧化应激、炎症反应和细胞凋亡的减弱,并通过ERK1/2、STAT1和NF-[式中:见正文]B途径进行调节。要证实 EGCG 对肾功能的保护作用,特别是对碘普罗米特等造影剂引起的损伤的保护作用,还需要进一步的研究。
{"title":"Bioinformatics Analysis and Experimental Validation of Epigallocatechin-3-gallate Against Iopromide-induced Injury in HEK-293 Cells <i>via</i> Anti-oxidative and Anti-inflammation Pathways.","authors":"Yuh-Feng Tsai, Chia-Wen Tsai, Jai-Sing Yang, Yu-Ning Juan, Hou-Yu Shih, DA-Tian Bau, Wen-Shin Chang","doi":"10.21873/invivo.13738","DOIUrl":"10.21873/invivo.13738","url":null,"abstract":"<p><strong>Background/aim: </strong>The administration of contrast agents can adversely affect kidney function. Nevertheless, the nephrotoxicity of iopromide in human renal cells, potential therapeutic agents, and the underlying molecular mechanisms have not been thoroughly investigated.</p><p><strong>Materials and methods: </strong>The proliferation of HEK-293 kidney cells was assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazoliumbromide (MTT) assay. Apoptotic cell death was examined using the TUNEL assay and caspase-3 activity measurements. The impacts and potential pathways of epigallocatechin-3-gallate (EGCG) on iopromide-induced renal damage were analyzed through whole transcriptome sequencing. The redox state was assessed by measuring reactive oxygen species (ROS) production and 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity.</p><p><strong>Results: </strong>Iopromide-induced inhibition of cell proliferation and apoptosis in HEK-293 cells was counteracted by EGCG co-treatment. Pathway analysis revealed that molecules related to antioxidant and anti-inflammatory responses, such as ERK1/2, STAT1, and NF-[Formula: see text]B, were pivotal in the action of EGCG.</p><p><strong>Conclusion: </strong>Iopromide-induced ROS production, decreased DPPH scavenging ability, DNA strand breaks, elevated caspase-3 activity, and reduced cell proliferation were all reversed by EGCG co-treatment in HEK-293 cells. The mechanisms likely involve the attenuation of oxidative stress, inflammatory responses, and apoptosis, with regulation through the ERK1/2, STAT1, and NF-[Formula: see text]B pathways. Further research is necessary to confirm the protective effects of EGCG on renal function, particularly against damage induced by contrast agents like iopromide.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2617-2628"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Nattokinase in D-galactose- and Aluminum Chloride-induced Alzheimer's Disease Model of Rat. 纳豆激酶对 D-半乳糖和氯化铝诱导的阿尔茨海默病大鼠模型的影响
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13744
Takashi Tanikawa, James Yu, Kate Hsu, Shinder Chen, Ayako Ishii, Masashi Kitamura

Background/aim: Alzheimer's disease (AD) is the most common form of dementia worldwide. Nattokinase is a serine protease extracellularly produced by natto, a fermented product of Bacillus subtilis var. natto. In this study, we investigated the therapeutic effects of nattokinase in a rat model of AD induced by aluminum and D-galactose.

Materials and methods: Forty Wistar rats were randomly divided into four groups: normal, vehicle, and orally administered nattokinase (NK65 and NK130 groups). Except for the normal group, all groups were treated with AlCl3 and D-galactose for 10 weeks. The NK65 and NK130 groups additionally received 65 mg/kg/day and 130 mg/kg/day nattokinase, respectively. We analyzed β-amyloid levels in the cerebrospinal fluid (CSF), and the spatial reference test was evaluated using the Morris water maze test. After the Morris water maze test, rats of all groups were subjected to micro-computed tomography (μCT) to assess constructional changes in the brain. Aluminum concentration and β-amyloid levels were analyzed by histochemical staining in all brain tissues.

Results: Oral administration of nattokinase in the AD rat model increased free-form β-amyloid levels in the CSF and improved aluminum and amyloid plaque accumulation in the brain. Brain μCT images showed enhanced brain volume with fewer constructional changes after treatment with nattokinase. In the behavioral tests, both the escape latency time in the spatial reference test and the time taken to cross the platform area in the spatial probe test improved partially.

Conclusion: The results suggest that nattokinase has potential therapeutic applications in the treatment of AD.

背景/目的:阿尔茨海默病(AD)是全球最常见的痴呆症。纳豆激酶是一种丝氨酸蛋白酶,由纳豆(一种枯草芽孢杆菌的发酵产物)在细胞外产生。本研究探讨了纳豆激酶对铝和D-半乳糖诱导的AD大鼠模型的治疗效果:将 40 只 Wistar 大鼠随机分为四组:正常组、给药组和口服纳豆激酶组(NK65 和 NK130 组)。除正常组外,其他各组均接受氯化铝和 D-半乳糖治疗 10 周。NK65组和NK130组还分别接受了65毫克/千克/天和130毫克/千克/天的纳豆激酶治疗。我们分析了脑脊液(CSF)中的β淀粉样蛋白水平,并使用莫里斯水迷宫测试评估了空间参照测试。在莫里斯水迷宫试验后,对所有组的大鼠进行显微计算机断层扫描(μCT),以评估大脑构造的变化。所有脑组织中的铝浓度和β-淀粉样蛋白水平均通过组织化学染色法进行分析:结果:在AD大鼠模型中口服纳豆激酶可增加脑脊液中游离态β淀粉样蛋白的水平,并改善铝和淀粉样斑块在大脑中的积聚。脑μCT图像显示,纳豆激酶治疗后脑容量增加,结构变化减少。在行为测试中,空间参照测试中的逃逸潜伏时间和空间探针测试中穿过平台区所需的时间都得到了部分改善:结果表明,纳豆激酶具有治疗AD的潜在应用价值。
{"title":"Effect of Nattokinase in D-galactose- and Aluminum Chloride-induced Alzheimer's Disease Model of Rat.","authors":"Takashi Tanikawa, James Yu, Kate Hsu, Shinder Chen, Ayako Ishii, Masashi Kitamura","doi":"10.21873/invivo.13744","DOIUrl":"10.21873/invivo.13744","url":null,"abstract":"<p><strong>Background/aim: </strong>Alzheimer's disease (AD) is the most common form of dementia worldwide. Nattokinase is a serine protease extracellularly produced by natto, a fermented product of Bacillus subtilis var. natto. In this study, we investigated the therapeutic effects of nattokinase in a rat model of AD induced by aluminum and D-galactose.</p><p><strong>Materials and methods: </strong>Forty Wistar rats were randomly divided into four groups: normal, vehicle, and orally administered nattokinase (NK65 and NK130 groups). Except for the normal group, all groups were treated with AlCl<sub>3</sub> and D-galactose for 10 weeks. The NK65 and NK130 groups additionally received 65 mg/kg/day and 130 mg/kg/day nattokinase, respectively. We analyzed β-amyloid levels in the cerebrospinal fluid (CSF), and the spatial reference test was evaluated using the Morris water maze test. After the Morris water maze test, rats of all groups were subjected to micro-computed tomography (μCT) to assess constructional changes in the brain. Aluminum concentration and β-amyloid levels were analyzed by histochemical staining in all brain tissues.</p><p><strong>Results: </strong>Oral administration of nattokinase in the AD rat model increased free-form β-amyloid levels in the CSF and improved aluminum and amyloid plaque accumulation in the brain. Brain μCT images showed enhanced brain volume with fewer constructional changes after treatment with nattokinase. In the behavioral tests, both the escape latency time in the spatial reference test and the time taken to cross the platform area in the spatial probe test improved partially.</p><p><strong>Conclusion: </strong>The results suggest that nattokinase has potential therapeutic applications in the treatment of AD.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2672-2679"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ischemic Postconditioning Mitigates Lipopolysaccharide-induced Acute Lung Injury in Rats. 缺血后条件缓解脂多糖诱发的大鼠急性肺损伤
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13748
Bilkay Serez Kaya, Selen Yildiz, Onur Ersoy, Ümmühan Erge, Ebru Taştekin, Özgür Gündüz, Oktay Kaya

Background/aim: Acute lung injury (ALI) is a syndrome characterized by the disruption of alveolar endothelial and epithelial barriers, neutrophilic infiltration in pulmonary regions, and non-cardiogenic edema, associated with high mortality and morbidity. Despite intensive research efforts, there is currently no approved specific treatment for the condition. The aim of this study was to investigate the potential beneficial effect of ischemic post-conditioning in lipopolysaccharide (LPS)-induced lung injury and its possible association with inflammatory and apoptotic processes.

Materials and methods: Lung injury was induced in rats by a single intraperitoneal administration of 10 mg/kg LPS. Under anesthesia, latex tourniquets were wrapped around both hind limbs of the animals in a region close to the body to achieve complete ischemia. The ischemic conditioning procedure consisted of four cycles of 10 min of ischemia followed by 10 min of reperfusion. Inflammation, and apoptosis levels were measured using ELISA. Hematoxylin and eosin staining was used for histopathological evaluation, while TUNEL staining was employed for apoptotic cell counting. One-way analysis of variance (ANOVA) with post hoc Tukey test was used for comparisons between groups.

Results: Intraperitoneal LPS administration induced neutrophil infiltration and apoptotic cell death in lung tissue. These effects were prevented by remote ischemic postconditioning (RIPostC) application. Additionally, the beneficial effects of ischemic conditioning can be transferred via serum.

Conclusion: RIPostC can ameliorate LPS-induced ALI. The mechanism of the protective effects of RIPostC may lie in the suppression of apoptosis and neutrophil infiltration.

背景/目的:急性肺损伤(ALI)是一种以肺泡内皮和上皮屏障破坏、肺区中性粒细胞浸润和非心源性水肿为特征的综合征,死亡率和发病率都很高。尽管开展了大量的研究工作,但目前还没有针对该病的获准特效疗法。本研究旨在探讨缺血后调节对脂多糖(LPS)诱导的肺损伤的潜在有益作用及其与炎症和细胞凋亡过程可能存在的关联:大鼠腹腔注射 10 毫克/千克 LPS,诱发肺损伤。在麻醉状态下,将乳胶止血带缠绕在动物双后肢靠近身体的区域,以达到完全缺血的目的。缺血调理过程包括 10 分钟缺血和 10 分钟再灌注的四个循环。使用 ELISA 测量炎症和细胞凋亡水平。组织病理学评估采用血红素和伊红染色法,凋亡细胞计数采用 TUNEL 染色法。组间比较采用单因素方差分析(ANOVA)和事后Tukey检验:结果:腹腔注射 LPS 可诱导中性粒细胞浸润和肺组织细胞凋亡。应用远端缺血后条件(RIPostC)可防止这些影响。此外,缺血调理的有益作用可通过血清转移:结论:RIPostC 可改善 LPS 诱导的 ALI。RIPostC的保护作用机制可能在于抑制细胞凋亡和中性粒细胞浸润。
{"title":"Ischemic Postconditioning Mitigates Lipopolysaccharide-induced Acute Lung Injury in Rats.","authors":"Bilkay Serez Kaya, Selen Yildiz, Onur Ersoy, Ümmühan Erge, Ebru Taştekin, Özgür Gündüz, Oktay Kaya","doi":"10.21873/invivo.13748","DOIUrl":"10.21873/invivo.13748","url":null,"abstract":"<p><strong>Background/aim: </strong>Acute lung injury (ALI) is a syndrome characterized by the disruption of alveolar endothelial and epithelial barriers, neutrophilic infiltration in pulmonary regions, and non-cardiogenic edema, associated with high mortality and morbidity. Despite intensive research efforts, there is currently no approved specific treatment for the condition. The aim of this study was to investigate the potential beneficial effect of ischemic post-conditioning in lipopolysaccharide (LPS)-induced lung injury and its possible association with inflammatory and apoptotic processes.</p><p><strong>Materials and methods: </strong>Lung injury was induced in rats by a single intraperitoneal administration of 10 mg/kg LPS. Under anesthesia, latex tourniquets were wrapped around both hind limbs of the animals in a region close to the body to achieve complete ischemia. The ischemic conditioning procedure consisted of four cycles of 10 min of ischemia followed by 10 min of reperfusion. Inflammation, and apoptosis levels were measured using ELISA. Hematoxylin and eosin staining was used for histopathological evaluation, while TUNEL staining was employed for apoptotic cell counting. One-way analysis of variance (ANOVA) with post hoc Tukey test was used for comparisons between groups.</p><p><strong>Results: </strong>Intraperitoneal LPS administration induced neutrophil infiltration and apoptotic cell death in lung tissue. These effects were prevented by remote ischemic postconditioning (RIPostC) application. Additionally, the beneficial effects of ischemic conditioning can be transferred via serum.</p><p><strong>Conclusion: </strong>RIPostC can ameliorate LPS-induced ALI. The mechanism of the protective effects of RIPostC may lie in the suppression of apoptosis and neutrophil infiltration.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2705-2711"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protection of Rabbits Against Colonization and Morbidity Associated With Toxigenic Pasteurella multocida by Immunization With Inactivated Heat-labile Toxin. 用灭活热嗜酸性毒素免疫家兔,防止多杀性巴氏杆菌引起的定植和发病。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13740
Mark A Suckow

Background/aim: Pasteurella multocida is a significant cause of morbidity and mortality in rabbits, as well as other species. Some isolates elaborate a heat-labile toxin (PMT) that has been shown to be an important virulence factor. Though previous studies have demonstrated protective immunity can be conferred via immunization of rabbits with heat-inactivated PMT (IPMT), we investigated the ability of immunization to impact colonization of P. multocida.

Materials and methods: Rabbits were immunized at days 0, 7 and 14 with either phosphate buffered saline (PBS), the mucosal adjuvant cholera toxin (CT), IMPT or IPMT + CT. Male New Zealand white rabbits were used and confirmed to be free of P. multocida prior to experimentation.

Results: Serum IgG and nasal lavage fluid IgA responses directed against PMT were found in rabbits immunized with IPMT, with or without CT, but not in those immunized with only PBS or CT; and the addition of CT to IPMT enhanced the response. Significantly more P. multocida CFUs (p≤0.05) were cultured from the lungs of rabbits immunized with IPMT, with or without CT, compared to those administered only PBS or CT, although no differences were observed in nasal lavage fluid samples. Further, immunization IPMT, with or without CT, conferred protection against pleuritis and pneumonia.

Conclusion: PMT, in addition to its role as a virulence factor, may serve as a colonization factor for P. multocida in the lungs of rabbits.

背景/目的:多杀性巴氏杆菌是导致兔子和其他物种发病和死亡的重要原因。一些分离株可产生一种热嗜性毒素(PMT),已被证明是一种重要的致病因子。尽管先前的研究表明,通过对兔子进行热灭活 PMT(IPMT)免疫可获得保护性免疫力,但我们还是研究了免疫对多杀菌素定植的影响能力:在第 0、7 和 14 天用磷酸盐缓冲盐水 (PBS)、粘膜佐剂霍乱毒素 (CT)、IMPT 或 IPMT + CT 对兔子进行免疫。实验使用雄性新西兰白兔,并在实验前确认其体内无多杀螨:结果:用IPMT(含或不含CT)免疫兔子的血清IgG和鼻腔灌洗液IgA都出现了针对PMT的反应,而只用PBS或CT免疫的兔子则没有;在IPMT中添加CT可增强反应。与只用 PBS 或 CT 免疫的兔子相比,用 IPMT(含或不含 CT)免疫的兔子肺部培养出的多杀菌素 CFU 明显较多(p≤0.05),但在鼻腔灌洗液样本中未观察到差异。此外,免疫 IPMT(含或不含 CT)可预防胸膜炎和肺炎:结论:PMT 除了是一种致病因子外,还可能是多杀性巴氏杆菌在兔子肺部的定植因子。
{"title":"Protection of Rabbits Against Colonization and Morbidity Associated With Toxigenic <i>Pasteurella multocida</i> by Immunization With Inactivated Heat-labile Toxin.","authors":"Mark A Suckow","doi":"10.21873/invivo.13740","DOIUrl":"10.21873/invivo.13740","url":null,"abstract":"<p><strong>Background/aim: </strong>Pasteurella multocida is a significant cause of morbidity and mortality in rabbits, as well as other species. Some isolates elaborate a heat-labile toxin (PMT) that has been shown to be an important virulence factor. Though previous studies have demonstrated protective immunity can be conferred via immunization of rabbits with heat-inactivated PMT (IPMT), we investigated the ability of immunization to impact colonization of P. multocida.</p><p><strong>Materials and methods: </strong>Rabbits were immunized at days 0, 7 and 14 with either phosphate buffered saline (PBS), the mucosal adjuvant cholera toxin (CT), IMPT or IPMT + CT. Male New Zealand white rabbits were used and confirmed to be free of P. multocida prior to experimentation.</p><p><strong>Results: </strong>Serum IgG and nasal lavage fluid IgA responses directed against PMT were found in rabbits immunized with IPMT, with or without CT, but not in those immunized with only PBS or CT; and the addition of CT to IPMT enhanced the response. Significantly more P. multocida CFUs (p≤0.05) were cultured from the lungs of rabbits immunized with IPMT, with or without CT, compared to those administered only PBS or CT, although no differences were observed in nasal lavage fluid samples. Further, immunization IPMT, with or without CT, conferred protection against pleuritis and pneumonia.</p><p><strong>Conclusion: </strong>PMT, in addition to its role as a virulence factor, may serve as a colonization factor for P. multocida in the lungs of rabbits.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2639-2644"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated With Mortality in Patients With Catheter-related Bloodstream Infection: A Multicenter Retrospective Study. 导管相关血流感染患者死亡率的相关因素:一项多中心回顾性研究
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13788
Akihiko Futamura, Takenao Koseki, Tsuyoshi Nakai, Nobuyuki Muroi, Michiaki Myotoku, Junichi Iida, Hiroki Maki, Akito Suzuki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui

Background/aim: Catheter-related bloodstream infections (CRBSI) are frequently life-threatening. Several factors have been reported to be related to CRBSI development; however, the factors associated with CRBSI mortality are unclear as they have rarely been studied. This study investigated the factors associated with mortality in patients with CRBSI, specifically focusing on nutritional factors.

Patients and methods: This retrospective, multicenter study included in-patients with acute conditions and convalescent patients diagnosed with a CRBSI between January 2019 and December 2021 at 33 hospitals (23 general hospitals, two mixed-care hospitals, and eight convalescent hospitals). The primary outcome was death. Unadjusted and multivariable logistic regression analysis was performed to identify factors associated with mortality.

Results: A total of 453 patients with CRBSI were enrolled. The causes of death were analyzed for 382 (84.3%) who survived CRBSI and 71 (15.7%) who died. Multivariable analysis revealed that Candida detected in blood culture [adjusted odds ratio (aOR)=2.72, 95% confidence interval (CI)=1.15-6.41; p=0.025)], CRBSI onset within 30 days of catheter insertion (aOR=2.28, 95% CI=1.27-4.09; p=0.005), concurrent infection (aOR=2.07, 95% CI=1.19-3.60; p=0.009), low serum albumin level (aOR=1.64, 95% CI=1.02-2.63; p=0.044), and elevated C-reactive protein level (aOR=1.05, 95% CI=1.01-1.10; p=0.028) were risk factors for mortality, whereas the use of a peripherally inserted central catheter was associated with a reduced risk of CRBSI mortality (aOR=0.30, 95% CI=0.13-0.69; p=0.004).

Conclusion: Enhanced monitoring of factors, such as candida detected in blood culture, CRBSI onset within 30 days of catheter insertion, concurrent infection, low serum albumin level, elevated C-reactive protein (CRP) level and the use of a peripherally inserted central catheter (PICC), is crucial for mitigating CRBSI severity and risk of death.

背景/目的:导管相关血流感染(CRBSI)常常危及生命。据报道,有几种因素与 CRBSI 的发生有关;然而,与 CRBSI 死亡率有关的因素还不清楚,因为这些因素很少被研究。本研究调查了与 CRBSI 患者死亡率相关的因素,尤其关注营养因素:这项回顾性多中心研究纳入了 33 家医院(23 家综合医院、2 家混合护理医院和 8 家疗养医院)在 2019 年 1 月至 2021 年 12 月期间确诊为 CRBSI 的急性病住院患者和疗养患者。主要结果为死亡。为确定与死亡率相关的因素,进行了未调整和多变量逻辑回归分析:结果:共纳入 453 名 CRBSI 患者。对 382 例(84.3%)CRBSI 存活患者和 71 例(15.7%)死亡患者的死因进行了分析。多变量分析显示,在血液培养中检测到念珠菌[调整几率比(aOR)=2.72,95% 置信区间(CI)=1.15-6.41;p=0.025)]、导管插入后 30 天内发生 CRBSI(aOR=2.28,95% CI=1.27-4.09;p=0.005)、并发感染(aOR=2.07,95% CI=1.19-3.60;p=0.009)、低血清白蛋白水平(aOR=1.64,95% CI=1.02-2.63;p=0.044)和C反应蛋白水平升高(aOR=1.05,95% CI=1.01-1.10;p=0.028)是死亡的危险因素,而使用外周插入中心导管与CRBSI死亡风险降低相关(aOR=0.30,95% CI=0.13-0.69;p=0.004):结论:加强监测血液培养中检测到的念珠菌、导管插入后30天内发生CRBSI、并发感染、血清白蛋白水平低、C反应蛋白(CRP)水平升高以及使用外周置入中心导管(PICC)等因素,对于降低CRBSI严重程度和死亡风险至关重要。
{"title":"Factors Associated With Mortality in Patients With Catheter-related Bloodstream Infection: A Multicenter Retrospective Study.","authors":"Akihiko Futamura, Takenao Koseki, Tsuyoshi Nakai, Nobuyuki Muroi, Michiaki Myotoku, Junichi Iida, Hiroki Maki, Akito Suzuki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui","doi":"10.21873/invivo.13788","DOIUrl":"10.21873/invivo.13788","url":null,"abstract":"<p><strong>Background/aim: </strong>Catheter-related bloodstream infections (CRBSI) are frequently life-threatening. Several factors have been reported to be related to CRBSI development; however, the factors associated with CRBSI mortality are unclear as they have rarely been studied. This study investigated the factors associated with mortality in patients with CRBSI, specifically focusing on nutritional factors.</p><p><strong>Patients and methods: </strong>This retrospective, multicenter study included in-patients with acute conditions and convalescent patients diagnosed with a CRBSI between January 2019 and December 2021 at 33 hospitals (23 general hospitals, two mixed-care hospitals, and eight convalescent hospitals). The primary outcome was death. Unadjusted and multivariable logistic regression analysis was performed to identify factors associated with mortality.</p><p><strong>Results: </strong>A total of 453 patients with CRBSI were enrolled. The causes of death were analyzed for 382 (84.3%) who survived CRBSI and 71 (15.7%) who died. Multivariable analysis revealed that Candida detected in blood culture [adjusted odds ratio (aOR)=2.72, 95% confidence interval (CI)=1.15-6.41; p=0.025)], CRBSI onset within 30 days of catheter insertion (aOR=2.28, 95% CI=1.27-4.09; p=0.005), concurrent infection (aOR=2.07, 95% CI=1.19-3.60; p=0.009), low serum albumin level (aOR=1.64, 95% CI=1.02-2.63; p=0.044), and elevated C-reactive protein level (aOR=1.05, 95% CI=1.01-1.10; p=0.028) were risk factors for mortality, whereas the use of a peripherally inserted central catheter was associated with a reduced risk of CRBSI mortality (aOR=0.30, 95% CI=0.13-0.69; p=0.004).</p><p><strong>Conclusion: </strong>Enhanced monitoring of factors, such as candida detected in blood culture, CRBSI onset within 30 days of catheter insertion, concurrent infection, low serum albumin level, elevated C-reactive protein (CRP) level and the use of a peripherally inserted central catheter (PICC), is crucial for mitigating CRBSI severity and risk of death.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"3041-3049"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Effect of the HCV Elimination With Direct-acting Antivirals on the Progression of Gastroesophageal Varices. 直接作用抗病毒药物消除丙肝病毒对胃食管静脉曲张进展的长期影响
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13779
Yukihisa Yuri, Takashi Nishimura, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Taro Kimura, Kohei Yoshihara, Ryota Yoshioka, Shoki Kawata, Yuta Kawase, Ryota Nakano, Hideyuki Shiomi, Shinya Fukunishi, Shinichiro Shinzaki, Hirayuki Enomoto

Background/aim: Gastroesophageal varices (GEV) hemorrhage is a serious complication that can lead to unfavorable outcomes in cirrhotic patients. However, the clinical impact of HCV elimination [sustained viral response (SVR)] by direct-acting antivirals (DAAs), particularly on the long-term effects on the endoscopic findings of GEV have not been sufficiently evaluated. This study aimed to investigate whether HCV elimination with DAA treatment suppresses the progression of GEV.

Patients and methods: The clinical courses of the endoscopic findings of GEV were retrospectively compared between patients without an SVR (non-SVR group: n=71) and those who achieved an SVR with DAAs (DAA-SVR group: n=38).

Results: At 1, 3, 5, and 7 years, the cumulative GEV progression rates were 8.7%, 32.8%, 45.6%, and 66.2%, respectively. At 3 years, the cumulative GEV progression rate in the DAA-SVR group was similar to that in the non-SVR group. Beyond 3 years, cases with GEV progression were found in the non-SVR group, but not in the DAA-SVR group. At 7 years, the cumulative GEV progression rate in the DAA-SVR group was significantly lower than that in the non-SVR group (p<0.05, log-rank test). Variceal hemorrhage occurred in eight patients in the non-SVR group, while no bleeding events were observed in the DAA-SVR group during the observational period [8/71 (11.3%) vs. 0/38 (0.0%), p<0.05].

Conclusion: DAA treatment suppresses the progression of GEV over the long term.

背景/目的:胃食管静脉曲张(GEV)出血是一种严重的并发症,可导致肝硬化患者的不良预后。然而,尚未充分评估直接作用抗病毒药物(DAAs)消除 HCV(持续病毒应答(SVR))的临床影响,尤其是对 GEV 内镜检查结果的长期影响。本研究旨在探讨通过 DAA 治疗消除 HCV 是否会抑制 GEV 的进展:回顾性比较了未获得 SVR 的患者(非 SVR 组:71 人)和使用 DAA 获得 SVR 的患者(DAA-SVR 组:38 人)的 GEV 内镜检查结果的临床过程:1年、3年、5年和7年时,累积GEV进展率分别为8.7%、32.8%、45.6%和66.2%。3年后,DAA-SVR组的累积GEV进展率与非SVR组相似。3 年后,非 SVR 组出现了 GEV 进展病例,但 DAA-SVR 组没有。7年后,DAA-SVR组的累积GEV进展率明显低于非SVR组(p结论:DAA治疗可长期抑制GEV的进展。
{"title":"Long-term Effect of the HCV Elimination With Direct-acting Antivirals on the Progression of Gastroesophageal Varices.","authors":"Yukihisa Yuri, Takashi Nishimura, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Taro Kimura, Kohei Yoshihara, Ryota Yoshioka, Shoki Kawata, Yuta Kawase, Ryota Nakano, Hideyuki Shiomi, Shinya Fukunishi, Shinichiro Shinzaki, Hirayuki Enomoto","doi":"10.21873/invivo.13779","DOIUrl":"10.21873/invivo.13779","url":null,"abstract":"<p><strong>Background/aim: </strong>Gastroesophageal varices (GEV) hemorrhage is a serious complication that can lead to unfavorable outcomes in cirrhotic patients. However, the clinical impact of HCV elimination [sustained viral response (SVR)] by direct-acting antivirals (DAAs), particularly on the long-term effects on the endoscopic findings of GEV have not been sufficiently evaluated. This study aimed to investigate whether HCV elimination with DAA treatment suppresses the progression of GEV.</p><p><strong>Patients and methods: </strong>The clinical courses of the endoscopic findings of GEV were retrospectively compared between patients without an SVR (non-SVR group: n=71) and those who achieved an SVR with DAAs (DAA-SVR group: n=38).</p><p><strong>Results: </strong>At 1, 3, 5, and 7 years, the cumulative GEV progression rates were 8.7%, 32.8%, 45.6%, and 66.2%, respectively. At 3 years, the cumulative GEV progression rate in the DAA-SVR group was similar to that in the non-SVR group. Beyond 3 years, cases with GEV progression were found in the non-SVR group, but not in the DAA-SVR group. At 7 years, the cumulative GEV progression rate in the DAA-SVR group was significantly lower than that in the non-SVR group (p<0.05, log-rank test). Variceal hemorrhage occurred in eight patients in the non-SVR group, while no bleeding events were observed in the DAA-SVR group during the observational period [8/71 (11.3%) vs. 0/38 (0.0%), p<0.05].</p><p><strong>Conclusion: </strong>DAA treatment suppresses the progression of GEV over the long term.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2968-2972"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal Outcome in Pregnant Women Undergoing Third Caesarean Section After Onset of Labor. 分娩后进行第三次剖腹产的孕妇的产妇结局
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13750
Michael Meier, Ardawan Ilkhanipur, Peter Mallmann, Björn Lampe

Background/aim: Our study compares repeat cesarian section with and without labor in progress and evaluates adverse maternal outcomes that could discourage pregnant women in planning labor at term or at least after 39 weeks of gestation as recommended due to benefits in neonatal outcome.

Patients and methods: In this retrospective study, we analyzed 191 patients undergoing third C-section and compared two groups of women of undergoing C-section either before or after the onset of labor. The primary outcome measure was the incidence of maternal morbidity. Values of p≤0.05 were regarded as significant.

Results: Comparing the two subgroups, we did not find any significant differences in the occurrence of maternal complications or severe acute morbidity except for incomplete uterine rupture (p=0.04).

Conclusion: Undergoing a third C-section after the start of labor has no relevant or adverse impact on maternal outcome. Therefore, elective repeat C-section can be planned in late weeks of gestation aiming at reducing neonatal morbidity. The higher rate of uterine dehiscence was not associated with other issues of severe acute maternal morbidity.

背景/目的:我们的研究比较了有临产和无临产的重复剖腹产,并评估了对产妇不利的结果,这些结果可能会阻止孕妇计划在足月或至少在妊娠 39 周后分娩,因为这对新生儿的预后有好处:在这项回顾性研究中,我们分析了191名接受第三次剖腹产的患者,并对两组在临产前或临产后接受剖腹产的产妇进行了比较。主要结果指标是产妇发病率。P≤0.05为差异有显著性:结果:比较两个亚组,除了子宫不完全破裂(P=0.04)外,我们没有发现产妇并发症或严重急性发病率有任何显著差异:结论:分娩开始后进行第三次剖腹产对产妇的预后没有相关或不利的影响。因此,可在妊娠晚期计划选择再次剖腹产,以降低新生儿发病率。较高的子宫开裂率与其他严重急性产妇发病率问题无关。
{"title":"Maternal Outcome in Pregnant Women Undergoing Third Caesarean Section After Onset of Labor.","authors":"Michael Meier, Ardawan Ilkhanipur, Peter Mallmann, Björn Lampe","doi":"10.21873/invivo.13750","DOIUrl":"10.21873/invivo.13750","url":null,"abstract":"<p><strong>Background/aim: </strong>Our study compares repeat cesarian section with and without labor in progress and evaluates adverse maternal outcomes that could discourage pregnant women in planning labor at term or at least after 39 weeks of gestation as recommended due to benefits in neonatal outcome.</p><p><strong>Patients and methods: </strong>In this retrospective study, we analyzed 191 patients undergoing third C-section and compared two groups of women of undergoing C-section either before or after the onset of labor. The primary outcome measure was the incidence of maternal morbidity. Values of p≤0.05 were regarded as significant.</p><p><strong>Results: </strong>Comparing the two subgroups, we did not find any significant differences in the occurrence of maternal complications or severe acute morbidity except for incomplete uterine rupture (p=0.04).</p><p><strong>Conclusion: </strong>Undergoing a third C-section after the start of labor has no relevant or adverse impact on maternal outcome. Therefore, elective repeat C-section can be planned in late weeks of gestation aiming at reducing neonatal morbidity. The higher rate of uterine dehiscence was not associated with other issues of severe acute maternal morbidity.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2718-2728"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2-/-, Fancg-/- (C57BL/6), Fancd2-/- (129/Sv) Mice. 化学致癌物(3-甲基胆蒽)诱导范可尼贫血症 Fancd2-/-、Fancg-/- (C57BL/6)、Fancd2-/- (129/Sv) 小鼠发生多形性横纹肌肉瘤。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13734
Renee Fisher, Michael W Epperly, Lora H Rigatti, Donna Shields, Joel S Greenberger, Anthony Green, Amitava Mukherjee

Background/aim: Radiation oncologists are reluctant to treat cancer in Fanconi Anemia (FA) patients due to their lack of homologous recombination repair of DNA strand breaks in normal tissues. To determine the therapeutic effects of irradiation and combination chemotherapy on cancer in syngeneic, radiosensitive FA mice, we derived transplantable cancers of the same genotype in three FA mouse strains.

Materials and methods: Fancd2-/- mice on a C57BL/6 or Sv/129 background and Fancg-/- mice (C57BL/6 background) that received 3-methylcholanthrene (3-MCA), were monitored for the development of subcutaneous tumors.

Results: Tumors were induced at the site of 3-MCA injection, and tumor cell lines were established and found to be transplantable. Explanted tumors were identified as pleomorphic/rhabdomyosarcomas using immunohistochemical biomarkers.

Conclusion: These transplantable FA mouse tumor cell lines should be valuable for testing effects of new radiation therapy protocols including FLASH high dose rate radiation delivery, immunotherapies, and combined radiation and chemotherapy treatments for radiosensitive FA patients.

背景/目的:由于范可尼贫血症(FA)患者缺乏正常组织中DNA链断裂的同源重组修复功能,放射肿瘤学家不愿意对其进行癌症治疗。为了确定辐照和联合化疗对辐射敏感的FA小鼠癌症的治疗效果,我们在三个FA小鼠品系中衍生出了相同基因型的可移植癌症:观察C57BL/6或Sv/129背景的Fancd2-/-小鼠和接受3-甲基胆蒽(3-MCA)治疗的Fancg-/-小鼠(C57BL/6背景)的皮下肿瘤发生情况:结果:在注射 3-MCA 的部位诱发了肿瘤,并建立了肿瘤细胞系,发现它们可以移植。用免疫组化生物标记物鉴定出取出的肿瘤为多形性/横纹肌肉瘤:结论:这些可移植的FA小鼠肿瘤细胞系对测试新的放射治疗方案(包括FLASH高剂量率放射治疗、免疫疗法以及针对放射敏感性FA患者的放化疗联合疗法)的效果很有价值。
{"title":"Chemical Carcinogen (3-Methylcholanthrene)-induced Pleomorphic Rhabdomyosarcomas in Fanconi Anemia Fancd2-/-, Fancg-/- (C57BL/6), Fancd2-/- (129/Sv) Mice.","authors":"Renee Fisher, Michael W Epperly, Lora H Rigatti, Donna Shields, Joel S Greenberger, Anthony Green, Amitava Mukherjee","doi":"10.21873/invivo.13734","DOIUrl":"10.21873/invivo.13734","url":null,"abstract":"<p><strong>Background/aim: </strong>Radiation oncologists are reluctant to treat cancer in Fanconi Anemia (FA) patients due to their lack of homologous recombination repair of DNA strand breaks in normal tissues. To determine the therapeutic effects of irradiation and combination chemotherapy on cancer in syngeneic, radiosensitive FA mice, we derived transplantable cancers of the same genotype in three FA mouse strains.</p><p><strong>Materials and methods: </strong>Fancd2-/- mice on a C57BL/6 or Sv/129 background and Fancg-/- mice (C57BL/6 background) that received 3-methylcholanthrene (3-MCA), were monitored for the development of subcutaneous tumors.</p><p><strong>Results: </strong>Tumors were induced at the site of 3-MCA injection, and tumor cell lines were established and found to be transplantable. Explanted tumors were identified as pleomorphic/rhabdomyosarcomas using immunohistochemical biomarkers.</p><p><strong>Conclusion: </strong>These transplantable FA mouse tumor cell lines should be valuable for testing effects of new radiation therapy protocols including FLASH high dose rate radiation delivery, immunotherapies, and combined radiation and chemotherapy treatments for radiosensitive FA patients.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2582-2590"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of Psychosomatic Factors and Personality Traits With the Severity of Melanoma. 心身因素和人格特质与黑色素瘤严重程度的相关性。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-01 DOI: 10.21873/invivo.13765
Konstantinos Kontoangelos, Vasiliki Nikolaou, Aggeliki Syrgianni, Sofia Tsiori, Charalabos Papageorgiou, Alexander Stratigos

Background/aim: Melanoma, as a type of skin cancer, has undoubtedly gathered the interest of the global community in recent years, due to its rising incidence. Patients suffering from melanoma experience effects on their mental health, mainly depression and anxiety disorders. The present study aimed to examine the association of melanoma with the psychosomatic burden, personality traits, and demographic factors of the participants.

Patients and methods: The psychometric instruments administered were: the Psychopathology Questionnaire (SCL-90), Beck Depression Scale (BDI), Eysenck Personality Questionnaire (EPQ), and Hostility Questionnaire (HDHQ). The research sample consisted of 80 cancer patients, of whom 57.5% were women and 42.5% men, and whose ages ranged from 15 to 85, with a mean age of 56.95 and a standard deviation of 13.52 years.

Results: The majority of patients presented introverted hostility (77.5%) and 22.5% presented extroverted hostility. Male cancer patients seemed to score on average statistically significantly higher on the self-criticism scale than females (4.44±2.31 vs. 3.17±1.98, p<0.01) The patients in an advanced stage scored statistically significantly higher on the phobic anxiety scale than the patients in the initial stage (5.17±3.60 vs. 2.86±2.04, p<0.01). Also, early-stage patients presented statistically significantly higher scores on the paranoid hostility scale than advanced-stage patients (2.00±1.18 vs. 1.37±0.89, p<0.05).

Conclusion: The majority of patients with melanoma presented introverted hostility, and those in advanced stages scored significantly higher on the phobic anxiety scale compared to the patients in the initial stage.

背景/目的:黑色素瘤是皮肤癌的一种,近年来,由于其发病率不断上升,无疑引起了全球社会的关注。黑色素瘤患者的心理健康会受到影响,主要是抑郁和焦虑症。本研究旨在探讨黑色素瘤与参与者的心身负担、人格特质和人口学因素之间的关联:使用的心理测量工具包括:精神病理学问卷(SCL-90)、贝克抑郁量表(BDI)、艾森克人格问卷(EPQ)和敌意问卷(HDHQ)。研究样本包括 80 名癌症患者,其中女性占 57.5%,男性占 42.5%,年龄从 15 岁到 85 岁不等,平均年龄为 56.95 岁,标准差为 13.52 岁:大多数患者表现出内向型敌意(77.5%),22.5%表现出外向型敌意。男性癌症患者在自我批评量表上的平均得分似乎明显高于女性(4.44±2.31 vs. 3.17±1.98,p):大多数黑色素瘤患者表现为内向型敌意,晚期患者在恐惧焦虑量表上的得分明显高于初期患者。
{"title":"Correlation of Psychosomatic Factors and Personality Traits With the Severity of Melanoma.","authors":"Konstantinos Kontoangelos, Vasiliki Nikolaou, Aggeliki Syrgianni, Sofia Tsiori, Charalabos Papageorgiou, Alexander Stratigos","doi":"10.21873/invivo.13765","DOIUrl":"10.21873/invivo.13765","url":null,"abstract":"<p><strong>Background/aim: </strong>Melanoma, as a type of skin cancer, has undoubtedly gathered the interest of the global community in recent years, due to its rising incidence. Patients suffering from melanoma experience effects on their mental health, mainly depression and anxiety disorders. The present study aimed to examine the association of melanoma with the psychosomatic burden, personality traits, and demographic factors of the participants.</p><p><strong>Patients and methods: </strong>The psychometric instruments administered were: the Psychopathology Questionnaire (SCL-90), Beck Depression Scale (BDI), Eysenck Personality Questionnaire (EPQ), and Hostility Questionnaire (HDHQ). The research sample consisted of 80 cancer patients, of whom 57.5% were women and 42.5% men, and whose ages ranged from 15 to 85, with a mean age of 56.95 and a standard deviation of 13.52 years.</p><p><strong>Results: </strong>The majority of patients presented introverted hostility (77.5%) and 22.5% presented extroverted hostility. Male cancer patients seemed to score on average statistically significantly higher on the self-criticism scale than females (4.44±2.31 vs. 3.17±1.98, p<0.01) The patients in an advanced stage scored statistically significantly higher on the phobic anxiety scale than the patients in the initial stage (5.17±3.60 vs. 2.86±2.04, p<0.01). Also, early-stage patients presented statistically significantly higher scores on the paranoid hostility scale than advanced-stage patients (2.00±1.18 vs. 1.37±0.89, p<0.05).</p><p><strong>Conclusion: </strong>The majority of patients with melanoma presented introverted hostility, and those in advanced stages scored significantly higher on the phobic anxiety scale compared to the patients in the initial stage.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"38 6","pages":"2844-2852"},"PeriodicalIF":1.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
In vivo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1